Prinocate 250 mg/62.5 mg Spot-on Solution for Large Dogs

Dosage schedule:
The recommended minimum doses are 10 mg/kg bodyweight imidacloprid and 2.5
mg/kg bodyweight moxidectin, equivalent to 0.1 ml/kg bodyweight.
The treatment schedule should be based on individual veterinary diagnosis and on
the local epidemiological situation.
Administer in accordance with the following table:
Dogs
[kg]
Pipette size to be used
Volume
[ml]
Imidacloprid
[mg/kg b.w.]
Moxidectin
[mg/kg b.w.]
>10-
imidacloprid/moxidectin 250
mg/62.5 mg spot-on solution for
large dogs
2.510-252.5-6.25
Flea treatment and prevention (Ctenocephalides felis)
One treatment prevents future flea infestation for 4 weeks. Pre-existing pupae in the
environment may emerge for 6 weeks or longer after treatment is initiated, depending
upon climatic conditions. Therefore, it may be necessary to combine treatment with
AN: 01755/2024 & 01759/2024
the veterinary medicinal product with environmental treatments aimed at breaking the
flea life cycle in the surroundings. This can result in a more rapid reduction in the
household flea population. The veterinary medicinal product should be administered
at monthly intervals when used as part of a treatment strategy for flea allergy
dermatitis.
Treatment of biting lice (Trichodectes canis)
A single dose should be administered. A further veterinary examination 30 days after
treatment is recommended as some animals may require a second treatment.
Treatment of ear mite infestation (Otodectes cynotis)
A single dose of the veterinary medicinal product should be administered. Loose
debris should be gently removed from the external ear canal at each treatment. A
further veterinary examination 30 days after treatment is recommended as some
animals may require a second treatment. Do not apply directly to the ear canal.
Treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis)
A single dose should be administered twice 4 weeks apart.
Treatment of demodicosis (caused by Demodex canis)
The administration of a single dose every 4 weeks for 2 to 4 months is efficacious
against
particularly in mild to moderate cases. Especially severe cases may require more
prolonged and more frequent treatment. To achieve the best possible response in
these severe cases, at the discretion of the veterinarian, the veterinary medicinal
product can be applied once a week and for a prolonged time. In all cases it is
essential that the treatment should be continued until skin scrapings are negative on
at least 2 consecutive monthly occasions. Treatment should be stopped in dogs that
show no improvement or do not respond in mite count after 2 months treatment.
Alternative treatment should be administered. Seek the advice of your veterinarian.
As demodicosis is a multi-factorial disease, where possible, it is advisable to also
treat any underlying disease appropriately.
Prevention of heartworm disease (D. immitis) and cutaneous dirofilariosis (skinworm)
(D. repens)
Dogs in areas endemic for heartworm, or those which have travelled to endemic
areas, may be infected with adult heartworms. Therefore prior to treatment with the
veterinary medicinal product, the advice provided in section 3.5 should be
considered. For prevention of heartworm disease and cutaneous dirofilariosis, the
veterinary medicinal product must be applied at regular monthly intervals during the
time of the year when mosquitoes (the intermediate hosts which carry and transmit D.
immitis and larvae) are present. The veterinary medicinal product may be
administered throughout the year or at least 1 month before the first expected
exposure to mosquitoes. Treatment should continue at regular monthly intervals until
1 month after the last exposure to mosquitoes. To establish a treatment routine, it is
AN: 01755/2024 & 01759/2024
recommended that the same day or date be used each month. When replacing
another heartworm preventative veterinary medicinal product in a heartworm
prevention programme, the first treatment with this veterinary medicinal product must
be given within 1 month of the last dose of the former medication. In non-endemic
areas there should be no risk of dogs having heartworm. Therefore they can be
treated without special precautions.
Treatment of microfilariae (D. immitis)
The veterinary medicinal product should be administered monthly for two consecutive
months.
Treatment of cutaneous dirofilariosis (skin worm) (adult stages of Dirofilaria repens)
The veterinary medicinal product should be administered monthly for six consecutive
months.
Reduction of microfilariae (skin worm) (D. repens)
The veterinary medicinal product should be administered monthly for four
consecutive months.
Treatment and prevention of Angiostrongylus vasorum
A single dose should be administered. A further veterinary examination 30 days after
treatment is recommended as some animals may require a second treatment. In
endemic areas regular monthly applications will prevent angiostrongylosis and patent
infection with Angiostrongylus vasorum.
Treatment of Crenosoma vulpis
A single dose should be administered.
Prevention of spirocercosis (Spirocerca lupi
The veterinary medicinal product should be administered monthly.
Treatment of Eucoleus (syn. Capillaria) boehmi (adults)
The veterinary medicinal product should be administered monthly for two consecutive
months. It is advisable to prevent auto-coprophagia between the two treatments in
order to prevent possible reinfection.
Treatment of the eye worm Thelazia callipaeda (adults)
A single dose of the veterinary medicinal product should be administered.
Roundworm, hookworm and whipworm treatment (Toxocara canis, Ancylostoma
caninum, Uncinaria stenocephala, Toxascaris leonina and Trichuris vulpis).
AN: 01755/2024 & 01759/2024
In areas endemic for heartworm, monthly treatment may significantly reduce the risk
of re-infection caused by the respective round-, hook- and whipworms. In areas non-
endemic for heartworm, the veterinary medicinal product can be used as part of a
seasonal prevention programme against fleas and gastrointestinal nematodes.
Studies have shown that monthly treatment of dogs will prevent infections caused by
Uncinaria stenocephala.
Method of administration:
1. Remove one pipette from the package. Hold applicator pipette in an upright
position, twist and pull cap off.
2. Turn the cap around and place the other end of cap back on pipette. Push and
twist the cap to break seal, and then remove the cap from the pipette.
3. With the dog standing still, part the coat between the shoulder blades until the
skin is visible. The product should only be applied to undamaged skin. Place the
tip of the pipette on the skin and squeeze firmly several times to empty the
contents directly onto the skin.